Exagen Inc. Profile Avatar - Palmy Investing

Exagen Inc.

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosi…

Medical - Diagnostics & Research
US, Vista [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of XGN's Analysis
CIK: 1274737 CUSIP: 30068X103 ISIN: US30068X1037 LEI: - UEI: -
Secondary Listings
XGN has no secondary listings inside our databases.